These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 35934321)
41. CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males. Spiller CM; Lobo J; Boellaard WPA; Gillis AJM; Bowles J; Looijenga LHJ Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32210110 [TBL] [Abstract][Full Text] [Related]
42. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours. Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818 [TBL] [Abstract][Full Text] [Related]
43. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy. Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ Cells; 2019 Oct; 8(10):. PubMed ID: 31597402 [TBL] [Abstract][Full Text] [Related]
44. Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence. Christiansen AJ; Lobo J; Fankhauser CD; Rothermundt C; Cathomas R; Batavia AA; Grogg JB; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Moch H; Beyer J; Hermanns T Front Oncol; 2022; 12():1056823. PubMed ID: 36568207 [TBL] [Abstract][Full Text] [Related]
45. Diagnostic performance of microRNAs in testicular germ cell tumors: a systematic review and meta-analysis. Zhao XY; Gao YL; Li DF; Liu HC; Zhu RF; Zhu CT Aging (Albany NY); 2021 Aug; 13(15):19657-19677. PubMed ID: 34343969 [TBL] [Abstract][Full Text] [Related]
46. Circulating MicroRNAs for Detection of Germ Cell Tumours: A Narrative Review. Fankhauser CD; Nuño MM; Murray MJ; Frazier L; Bagrodia A Eur Urol Focus; 2022 May; 8(3):660-662. PubMed ID: 35537936 [TBL] [Abstract][Full Text] [Related]
47. Cellular origin of microRNA-371a-3p in healthy males based on systematic urogenital tract tissue evaluation. Boellaard WPA; Gillis AJM; van Leenders GJLH; Stoop H; van Agthoven T; Dorssers LCJ; Dinkelman-Smit M; Boormans JL; Looijenga LHJ Andrology; 2019 Jul; 7(4):463-468. PubMed ID: 30786164 [TBL] [Abstract][Full Text] [Related]
48. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series. Anheuser P; Radtke A; Wülfing C; Kranz J; Belge G; Dieckmann KP Urol Int; 2017; 99(1):98-103. PubMed ID: 28586780 [TBL] [Abstract][Full Text] [Related]
49. The present and future of serum diagnostic tests for testicular germ cell tumours. Murray MJ; Huddart RA; Coleman N Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472 [TBL] [Abstract][Full Text] [Related]
50. Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis. Myklebust MP; Rosenlund B; Gjengstø P; Bercea BS; Karlsdottir Á; Brydøy M; Dahl O Front Genet; 2019; 10():463. PubMed ID: 31191602 [TBL] [Abstract][Full Text] [Related]
51. Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study. Belge G; Dumlupinar C; Nestler T; Klemke M; Törzsök P; Trenti E; Pichler R; Loidl W; Che Y; Hiester A; Matthies C; Pichler M; Paffenholz P; Kluth L; Wenzel M; Sommer J; Heinzelbecker J; Schriefer P; Winter A; Zengerling F; Kramer MW; Lengert M; Frey J; Heidenreich A; Wülfing C; Radtke A; Dieckmann KP Clin Cancer Res; 2024 Jan; 30(2):404-412. PubMed ID: 37967143 [TBL] [Abstract][Full Text] [Related]
52. Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels. Fankhauser CD; Wettstein MS; Christiansen AJ; Rothermundt C; Cathomas R; Kaufmann E; Sigg S; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Beyer J; Hermanns T Urol Oncol; 2024 Dec; 42(12):455.e9-455.e13. PubMed ID: 39261117 [TBL] [Abstract][Full Text] [Related]
53. miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up. Chavarriaga J; Hamilton RJ Andrology; 2023 May; 11(4):628-633. PubMed ID: 36373757 [TBL] [Abstract][Full Text] [Related]
54. Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors? Spiekermann M; Dieckmann KP; Balks T; Bullerdiek J; Belge G Anticancer Res; 2015 Jan; 35(1):117-21. PubMed ID: 25550541 [TBL] [Abstract][Full Text] [Related]
55. Editorial by Bendu K. Konneh, John T. Lafin and Aditya Bagrodia on pp. 341-342 of this issue: MicroRNA-371a-3p as a blood-based biomarker in testis cancer. Ahmadi H; Jang TL; Daneshmand S; Ghodoussipour S Asian J Urol; 2021 Oct; 8(4):400-406. PubMed ID: 34765447 [TBL] [Abstract][Full Text] [Related]